1,684
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Tripartite motif 27 promotes cardiac hypertrophy via PTEN/Akt/mTOR signal pathways

, , , &
Pages 8321-8331 | Received 30 Nov 2021, Accepted 04 Mar 2022, Published online: 21 Mar 2022

References

  • Ba L, Gao J, Chen Y, et al. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways. Phytomedicine. 2019;58:152765.
  • Kohli S, Ahuja S, Rani V. Transcription factors in heart: promising therapeutic targets in cardiac hypertrophy. Curr Cardiol Rev. 2011;7(4):262–271.
  • Shang L, Pin L, Zhu S, et al. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3beta signaling pathway. Chem Biol Interact. 2019;307:21–28.
  • Teekakirikul P, Zhu W, Huang HC, et al. Hypertrophic cardiomyopathy: an overview of genetics and management. Biomolecules. 2019;9(12):878.
  • Gupta I, Varshney NK, Khan S. Emergence of members of TRAF and DUB of ubiquitin proteasome system in the regulation of hypertrophic cardiomyopathy. Front Genet. 2018;9:336.
  • Mohammad Mahabub-Uz Zaman TN, Takagi T, Okamura T, et al. Ubiquitination-Deubiquitination by the TRIM27-USP7 complex regulates tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol. 2013;33(24):4971–4984.
  • van Gent M, Sparrer KMJ, Gack MU. TRIM proteins and their roles in antiviral host defenses. Annu Rev Virol. 2018;5(1):385–405.
  • Hatakeyama S. TRIM family proteins: roles in autophagy, immunity, and carcinogenesis. Trends Biochem Sci. 2017;42(4):297–311.
  • Ma L, Yao N, Chen P, et al. TRIM27 promotes the development of esophagus cancer via regulating PTEN/AKT signaling pathway. Cancer Cell Int. 2019;19(1):283.
  • Zheng Q, Hou J, Zhou Y, et al. Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27. Cell Res. 2015;25(10):1121–1136.
  • Cai J, Chen HY, Peng SJ, et al. USP7-TRIM27 axis negatively modulates antiviral type I IFN signaling. FASEB J. 2018;32(10):5238–5249.
  • Zaman MM, Shinagawa T, Ishii S. Trim27 -deficient mice are susceptible to streptozotocin-induced diabetes. FEBS Open Bio. 2013b;4(1):60–64.
  • Zaman MM, Nomura T, Takagi T, et al. Ubiquitination-deubiquitination by the TRIM27-USP7 complex regulates tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol. 2013a;33(24):4971–4984.
  • Wang J, Teng JL, Zhao D, et al. The ubiquitin ligase TRIM27 functions as a host restriction factor antagonized by Mycobacterium tuberculosis PtpA during mycobacterial infection. Sci Rep. 2016;6(1):34827.
  • Conwell SE, White AE, Harper JW, et al. Identification of TRIM27 as a novel degradation target of herpes simplex virus 1 ICP0. J Virol. 2015;89(1):220–229.
  • Ma Y, Wei Z, Bast RC Jr., et al. Downregulation of TRIM27 expression inhibits the proliferation of ovarian cancer cells in vitro and in vivo. Lab Invest. 2016;96(1):37–48.
  • Zhang HX, Xu ZS, Lin H, et al. TRIM27 mediates STAT3 activation at retromer-positive structures to promote colitis and colitis-associated carcinogenesis. Nat Commun. 2018;9(1):3441.
  • Jiang J, Xie C, Liu Y, et al. Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27. Biomed Pharmacother. 2019;109:595–601.
  • Zheng F, Xu N, Zhang Y. TRIM27 promotes hepatitis C virus replication by suppressing Type I interferon response. Inflammation. 2019;42(4):1317–1325.
  • Srivastava S, Cai X, Li Z, et al. Phosphatidylinositol-3-kinase C2beta and TRIM27 function to positively and negatively regulate IgE receptor activation of mast cells. Mol Cell Biol. 2012;32(15):3132–3139.
  • Liu J, Feng X, Tian Y, et al. Knockdown of TRIM27 expression suppresses the dysfunction of mesangial cells in lupus nephritis by FoxO1 pathway. J Cell Physiol. 2019;234(7):11555–11566.
  • Cai X, Srivastava S, Sun Y, et al. Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II PI3K-C2beta. Proc Natl Acad Sci U S A. 2011;108(50):20072–20077.
  • Pan J, Xu Z, Guo G, et al. 2021Circ_nuclear factor I X (circNfix) attenuates pressure overload-induced cardiac hypertrophy via regulating miR-145-5p/ATF3 axis. Bioengineered. 2021;12(1):5373–5385.
  • Shuai W, Kong B, Fu H, et al. Loss of MD1 increases vulnerability to ventricular arrhythmia in diet-induced obesity mice via enhanced activation of the TLR4/MyD88/CaMKII signaling pathway. Nutr Metab Cardiovasc Dis. 2019;29(9):991–998.
  • Li Z, Guo Z, Lan R, Cai S, Lin Z, Li J, Wang J, Li Z, Liu P. The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy. Acta Pharm Sin B. 2021;11(5):1286–1299.
  • Li Y, Shi Y, He Y, et al. RNA binding Motif protein-38 regulates myocardial hypertrophy in LXR-α-dependent lipogenesis pathway. Bioengineered. 2021b;12(2):9655–9667.
  • Ciocci Pardo A, Diaz RG, Gonzalez Arbelaez LF, et al. Benzolamide perpetuates acidic conditions during reperfusion and reduces myocardial ischemia-reperfusion injury. J Appl Physiol. 2018;125(2):340–352. 1985.
  • Rababa’h AM, Guillory AN, Mustafa R, et al. Oxidative stress and cardiac remodeling: an updated edge. Curr Cardiol Rev. 2018;14(1):53–59.
  • Lampada A, Hochhauser D, Salomoni P. Autophagy and receptor tyrosine kinase signalling: a mTORC2 matter. Cell Cycle. 2017b;16(20):1855–1856.
  • Jaworska AM, Wlodarczyk NA, Mackiewicz A, et al. The role of TRIM family proteins in the regulation of cancer stem cell self-renewal. Stem Cells. 2020;38(2):165–173.
  • Zaman MM, Shinagawa T, Ishii S. Trim27 -deficient mice are susceptible to streptozotocin-induced diabetes. FEBS Open Bio. 2013;4(1):60–64.
  • Li Y, Meng Q, Wang L, et al. TRIM27 protects against cardiac ischemia-reperfusion injury by suppression of apoptosis and inflammation via negatively regulating p53. Biochem Biophys Res Commun. 2021a;557:127–134.
  • He B, Tang RH, Weisleder N, et al. Enhancing muscle membrane repair by gene delivery of MG53 ameliorates muscular dystrophy and heart failure in delta-Sarcoglycan-deficient hamsters. Mol Ther. 2012;20(4):727–735.
  • Wang Y, Hao Y, Zhao Y, et al. TRIM28 and TRIM27 are required for expressions of PDGFRbeta and contractile phenotypic genes by vascular smooth muscle cells. FASEB J. 2020;34(5):6271–6283.
  • Braz JC, Gill RM, Corbly AK, et al. Selective activation of PI3Kalpha/Akt/GSK-3beta signalling and cardiac compensatory hypertrophy during recovery from heart failure. Eur J Heart Fail. 2009;11(8):739–748.
  • Yu P, Zhang Y, Li C, et al. Class III PI 3K-mediated prolonged activation of autophagy plays a critical role in the transition of cardiac hypertrophy to heart failure. J Cell Mol Med. 2015;19(7):1710–1719.
  • Tian M, Jiang X, Li X, et al. LKB1IP promotes pathological cardiac hypertrophy by targeting PTEN/Akt signalling pathway. J Cell Mol Med. 2021;25(5):2517–2529.
  • Yang H, Wang XX, Zhou CY, et al. Tripartite motif 10 regulates cardiac hypertrophy by targeting the PTEN/AKT pathway. J Cell Mol Med. 2020;24(11):6233–6241.